FOXP3 and systemic lupus erythematosus: Interestingly, another study showed a higher level of CTLA-4 in FOXP3- T cells from patients with SLE compared to other autoimmune diseases and healthy controls, but their study indicated that the FOXP3- T cells in SLE patients were unable to control activation and proliferation of effector T cells (121).